Oral retinoic acid as therapy for erythrokeratoderma variabilis.
Oral retinoic acid successfully and rapidly helped two patients with erythrokeratoderma variabilis. Treatment had to be maintained to prevent recurrence and no side effects have been observed so far.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D003873:Dermatitis, Exfoliative / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007642:Keratosis / Q000188:drug therapy*; D013997:Time Factors; D014212:Tretinoin / Q000008:administration & dosage / Q000627:therapeutic use*; D014801:Vitamin A / Q000031:analogs & derivatives*
D014801:Vitamin A; D014212:Tretinoin